No Data
No Data
No Data
No Data
No Data
Aadi Bioscience, Inc. (NASDAQ:AADI) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Aadi Bioscience, Inc. (NASDAQ:AADI) shares have retraced a considerable 25% in the last month, reversing a fair amount of their solid recent performance. For any long-term shareholders, the last mo
Simply Wall StApr 28 22:07
Aadi Biosciences(AADI.US) Officer Sells US$90,614.17 in Common Stock
$Aadi Biosciences(AADI.US)$ Officer Desai Neil sold 40,000 shares of Common Stock on Apr 1, 2, 2024 at an average price of $2.2654 for a total value of $90,614.17.Source: Announcement What is statemen
Futu NewsApr 4 05:33
Reported Sunday, Aadi Bioscience Presented New Subgroup Analysis Of Patients With Advanced Malignant PEComa Of Gynecologic Origin Treated With Nab-Sirolimus At Society Of Gynecologic Oncology
Subgroup experienced efficacy and safety consistent with overall study populationAdvanced malignant PEComa tumors of gynecologic origin accounted for more than half of the evaluable patients enrolled
BenzingaMar 18 14:24
Aadi Bioscience Presents New Subgroup Analysis of Patients With Advanced Malignant PEComa of Gynecologic Origin Treated With Nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers...
PR NewswireMar 17 20:00
Earnings Call Summary | Aadi Biosciences(AADI.US) Q4 2023 Earnings Conference
The following is a summary of the Aadi Bioscience, Inc. (AADI) Q4 2023 Earnings Call Transcript:Financial Performance:Aadi Bioscience reported impressive sales growth with full-year sales for FYARRO h
Futu NewsMar 14 00:13 · Conference Call
Aadi Bioscience Cash Runway Extends to 4Q 2025 >AADI
Aadi Bioscience Cash Runway Extends to 4Q 2025 >AADI
Dow JonesMar 13 20:04
No Data
No Data